CRDA Share Price Performance
UK£0
-32.83 (-100.00%)
Price UK£0
Fair ValueUK£34.46
Share Pricen/a
Croda International Plc's (LON:CRDA) Popularity With Investors Is Clear
Jan 06
Croda International Plc Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 40 Fair Values set on narratives written by author
CRDA Community Narratives
AN
Fair Value UK£34.46 23.0% undervalued intrinsic discount
CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year
0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
Fair Value UK£23 15.4% overvalued intrinsic discount
Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value UK£48.67 45.4% undervalued intrinsic discount
Sustainable Biotech Ingredients Will Capture Global Specialty Demand
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
Sustainable Biotech Ingredients Will Capture Global Specialty Demand
Key Takeaways Expansion in emerging markets and focus on sustainable ingredients are positioning Croda for premium pricing and robust long-term revenue growth. Operational efficiency and capital discipline are expected to boost margins and free cash flow, supporting enhanced shareholder returns.Read more
20
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
UK£48.67
45.4% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
6.99% p.a.
Profit Margin
13.75%
Future PE
30.46x
Price in 2029
UK£61.27
CRDA: Activist Pressure And Sector Outlook Will Drive Share Performance This Year
Key Takeaways Leadership in sustainable, bio-based chemicals and ongoing green R&D positions Croda to capture higher-margin market share amid rising eco-friendly product demand. Strategic expansion into emerging markets and partnerships with local brands drive sales growth, geographic diversification, and enhance revenue stability.Read more
169
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
20users have followed this narrative
AN
UK£34.46
23.0% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
4.83% p.a.
Profit Margin
13%
Future PE
24.26x
Price in 2028
UK£43.24
Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain
Key Takeaways Regulatory pressures and bans threaten revenue growth, while delays adapting to sustainability and ESG expectations could erode price premiums and reputation. Investments in new capacity risk underutilization amid slower life sciences demand, with prolonged innovation cycles and supply chain volatility adding to margin uncertainty.Read more
18
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
UK£23
15.4% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
1.85% p.a.
Profit Margin
12.77%
Future PE
17.79x
Price in 2028
UK£28.58
Trending Discussion
Recently Updated Narratives
AN
CRDA: Refreshed Q4 Guidance And Earnings Outlook Will Support Higher Share Price
Fair Value: UK£48.67 45.4% undervalued intrinsic discount
2 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CRDA: Activist Pressure Will Drive Future Reappraisal Of Margin Resilience
Fair Value: UK£34.46 23.0% undervalued intrinsic discount
20 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Rising Regulation Will Threaten Specialty Chemicals Though Tailwinds Remain
Fair Value: UK£23 15.4% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Croda International Plc Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Feb 24, 2026
- 1.00
- 45.10%
- 8.39%
- 29.5%
About CRDA
- Founded
- 1925
- Employees
- 6027
- CEO
- WebsiteView website
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
